On the 17-Dec-15 (Thursday), the US FDA issued a Warning Letter to Sun Pharmaceuticals . The letter was in relation to the inspection performed from 8-19 September, 2014, at the Pharmaceutical manufacturing facility, Halol-Baroda Highway, Halol, Gujarat . Sun Pharmaceuticals confirmed the receipt of the US FDA Warning Letter on the 19-Dec-15 (Saturday) – after the markets had closed for the week. ( refer here for the Original Copy ). This is what the company had to say about it: The company also held a conference call to assure investor sentiments on the 19-Dec-15 (Saturday). Here are some excerpts: Nimesh Desai from Investor Relations and Dilip Sanghvi, MD of Sun Pharmaceutical Industries. Statement: While more clarify on this will emerge going forward, we are co-operating with US FDA to ensure complete satisfaction of Halol Facility. Our understanding and way forward: Our initial reading of the warning letter indicates that it is based on the 483 observations from September, 2014. … (Read On…)
[via Capital Mind » Capital Mind]
Follow us @investmentheat – lists / @sectorheat